139 related articles for article (PubMed ID: 15777246)
1. Multiple mechanisms of cytokine action in neurodegenerative and psychiatric states: neurochemical and molecular substrates.
Hayley S; Anisman H
Curr Pharm Des; 2005; 11(8):947-62. PubMed ID: 15777246
[TBL] [Abstract][Full Text] [Related]
2. Neurotransmitter, peptide and cytokine processes in relation to depressive disorder: comorbidity between depression and neurodegenerative disorders.
Anisman H; Merali Z; Hayley S
Prog Neurobiol; 2008 May; 85(1):1-74. PubMed ID: 18346832
[TBL] [Abstract][Full Text] [Related]
3. Inflammation in Parkinson's diseases and other neurodegenerative diseases: cause and therapeutic implications.
Wilms H; Zecca L; Rosenstiel P; Sievers J; Deuschl G; Lucius R
Curr Pharm Des; 2007; 13(18):1925-8. PubMed ID: 17584117
[TBL] [Abstract][Full Text] [Related]
4. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
[TBL] [Abstract][Full Text] [Related]
5. Microglial cells in neurodegenerative disorders.
Wojtera M; Sikorska B; Sobow T; Liberski PP
Folia Neuropathol; 2005; 43(4):311-21. PubMed ID: 16416395
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of Glutaredoxin-1 Activates Microglia and Promotes Neurodegeneration: Implications for Parkinson's Disease.
Gorelenkova Miller O; Behring JB; Siedlak SL; Jiang S; Matsui R; Bachschmid MM; Zhu X; Mieyal JJ
Antioxid Redox Signal; 2016 Dec; 25(18):967-982. PubMed ID: 27224303
[TBL] [Abstract][Full Text] [Related]
7. Cognitive and behavioral dysfunction in Parkinson's disease: neurochemical and clinicopathological contributions.
Zgaljardic DJ; Foldi NS; Borod JC
J Neural Transm (Vienna); 2004 Oct; 111(10-11):1287-301. PubMed ID: 15480839
[TBL] [Abstract][Full Text] [Related]
8. The pathogenesis of clinical depression: stressor- and cytokine-induced alterations of neuroplasticity.
Hayley S; Poulter MO; Merali Z; Anisman H
Neuroscience; 2005; 135(3):659-78. PubMed ID: 16154288
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of synapse and dendrite maintenance and their disruption in psychiatric and neurodegenerative disorders.
Lin YC; Koleske AJ
Annu Rev Neurosci; 2010; 33():349-78. PubMed ID: 20367247
[TBL] [Abstract][Full Text] [Related]
10. Cytokines as a stressor: implications for depressive illness.
Anisman H; Hayley S; Turrin N; Merali Z
Int J Neuropsychopharmacol; 2002 Dec; 5(4):357-73. PubMed ID: 12466035
[TBL] [Abstract][Full Text] [Related]
11. Chronic Brain Inflammation: The Neurochemical Basis for Drugs to Reduce Inflammation.
Jarrott B; Williams SJ
Neurochem Res; 2016 Mar; 41(3):523-33. PubMed ID: 26177578
[TBL] [Abstract][Full Text] [Related]
12. Role of neuroinflammation in neurodegenerative diseases (Review).
Chen WW; Zhang X; Huang WJ
Mol Med Rep; 2016 Apr; 13(4):3391-6. PubMed ID: 26935478
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of the JAK/STAT Pathway Protects Against α-Synuclein-Induced Neuroinflammation and Dopaminergic Neurodegeneration.
Qin H; Buckley JA; Li X; Liu Y; Fox TH; Meares GP; Yu H; Yan Z; Harms AS; Li Y; Standaert DG; Benveniste EN
J Neurosci; 2016 May; 36(18):5144-59. PubMed ID: 27147665
[TBL] [Abstract][Full Text] [Related]
14. Effects of enriched environment on animal models of neurodegenerative diseases and psychiatric disorders.
Laviola G; Hannan AJ; Macrì S; Solinas M; Jaber M
Neurobiol Dis; 2008 Aug; 31(2):159-68. PubMed ID: 18585920
[TBL] [Abstract][Full Text] [Related]
15. Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders.
Mattson MP; Shea TB
Trends Neurosci; 2003 Mar; 26(3):137-46. PubMed ID: 12591216
[TBL] [Abstract][Full Text] [Related]
16. Reelin-mediated signaling in neuropsychiatric and neurodegenerative diseases.
Knuesel I
Prog Neurobiol; 2010 Aug; 91(4):257-74. PubMed ID: 20417248
[TBL] [Abstract][Full Text] [Related]
17. Cytokines as a precipitant of depressive illness: animal and human studies.
Anisman H; Merali Z; Poulter MO; Hayley S
Curr Pharm Des; 2005; 11(8):963-72. PubMed ID: 15777247
[TBL] [Abstract][Full Text] [Related]
18. Neuroendocrinology of neurodegenerative diseases. Insights from transgenic mouse models.
González De Aguilar JL; René F; Dupuis L; Loeffler JP
Neuroendocrinology; 2003 Nov; 78(5):244-52. PubMed ID: 14657605
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-6, a mental cytokine.
Spooren A; Kolmus K; Laureys G; Clinckers R; De Keyser J; Haegeman G; Gerlo S
Brain Res Rev; 2011 Jun; 67(1-2):157-83. PubMed ID: 21238488
[TBL] [Abstract][Full Text] [Related]
20. Neurodegeneration and inflammation in Parkinson's disease.
Phani S; Loike JD; Przedborski S
Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1():S207-9. PubMed ID: 22166436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
